United States & Johnson & Johnson
27 shared events · Importance 4 · Last updated Aug 12, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
United States: The US is part of North America, which held the largest market share in 2025, supported by strong regulatory frameworks and advanced manufacturing.
Johnson & Johnson: Johnson & Johnson is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Jul 28, 2026 · 6 articles
Business
United States: Part of North American Cobalt Inc., the largest regional market with 38.5% share.
Johnson & Johnson: Key player; growth forecast positive for its medical devices segment.
Jul 21, 2026 · 8 articles
Accidents
United States: United States>>> has bolstered precautions, including screening air passengers and suspending visa services, and has provided $13 million in assistance for the response.
Johnson & Johnson: Johnson & Johnson Innovative Medicine is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.
May 15, 2026 · 446 articles
Domestic
United States: The United States economy faces uncertainty due to new tariffs, with potential for higher inflation, dampened hiring, and increased costs for consumers and businesses.
Johnson & Johnson: Johnson & Johnson, along with other pharmaceutical companies, had previously announced investments in U.S. production due to the threat of tariffs, but the new, higher tariffs introduce further uncertainty.
Sep 26, 2025 · 7 articles
Tech
United States: The United States>>> is a key market for prostate cancer treatment, with a significant number of high-risk patients who could benefit from Apalutamide>>>.
Johnson & Johnson: The company developed and tested Apalutamide, a prostate cancer drug, which showed significant positive results in late-stage trials, potentially expanding its market and revenue.
May 31, 2026 · 6 articles
Regulatory
United States: The litigation is taking place in U.S. federal and state courts, affecting the company's operations in the U.S.
Johnson & Johnson: Johnson & Johnson is the defendant in the talc litigation; the judge's doubt on causation is favorable for the company, reducing the risk of large verdicts.
Jul 22, 2026 · 6 articles
Business
United States: The settlement resolves claims in U.S. federal and state courts, covering nearly all remaining talc lawsuits in the country.
Johnson & Johnson: Johnson & Johnson is the defendant proposing the $5.5 billion settlement to resolve most talc lawsuits, which could end a decade-long legal battle and reduce uncertainty.
Jul 27, 2026 · 82 articles
International
United States: The United States successfully used a drone boat for a rescue mission near the Strait of Hormuz, highlighting its push to integrate autonomous technology into Middle East operations.
Johnson & Johnson: Johnson & Johnson, a supply chain consultant, warns that the war's impact on costs will filter through supply chains for the rest of the year, leading to bigger problems if oil shortages persist.
May 05, 2026 · 374 articles
Regulatory
United States: The U.S. is waging war on Iran alongside Israel, contributing to helium supply disruptions that prompted China's export ban.
Johnson & Johnson: Johnson & Johnson, senior partner at Tidalwave Solutions, stated that the ban indicates China knows there is not enough helium.
Apr 20, 2026 · 23 articles
Domestic
United States: The US is involved through proclamations and greetings, highlighting strong bilateral ties. This may support continued cooperation in defence, technology, and trade.
Johnson & Johnson: US Congressman sent greetings. Symbolic.
Aug 05, 2026 · 128 articles
Domestic
United States: The United States also shuttered last week due to Donald Trump's demands, indicating a broader impact of his influence on the legislative process.
Johnson & Johnson: Johnson & Johnson, a Republican Representative, voiced frustration over the current state of Congress, stating that many colleagues have 'forgotten how to govern'.
Jun 29, 2026 · 17 articles
Regulatory
United States: Jurisdiction; political involvement via Trump administration; FDA and CDC mentioned.
Johnson & Johnson: Former parent of Kenvue; spun off in 2023, not directly involved but legacy exposure.
Jul 13, 2026 · 23 articles
Business
United States: The United States>>> is the target market for the biosimilar applications, with the United States — Food and Drug Administration>>> (FDA) being the regulatory authority for approval.
Johnson & Johnson: Johnson & Johnson>>> owns the trademarks for Simponi and Simponi Aria, the reference products for Alvogen>>>'s AVT05 biosimilar. The potential market entry of AVT05 could introduce competition to Johnson & Johnson>>>'s products.
Jun 04, 2026 · 10 articles
Business
United States: The United States is the primary market for the therapies and the regulatory environment is influenced by the Trump administration's executive order.
Johnson & Johnson: Johnson & Johnson faces new competition in the treatment-resistant depression market as Lilly's acquisition of Atai Life Sciences positions BPL-003 as a potential rival to J&J's Spravato.
Jul 16, 2026 · 25 articles
Business
United States: The United States is the region where Roche and Nurix Therapeutics, Inc. will equally split profits and losses from the commercialization of bexobrutideg.
Johnson & Johnson: Johnson & Johnson is mentioned as a co-developer of an approved BTK inhibitor, Imbruvica, which is a competitor to bexobrutideg.
Jun 07, 2026 · 22 articles
Business
Johnson & Johnson: Johnson & Johnson is facing a mass class-action lawsuit in the United Kingdom and ongoing litigation in the United States over allegations that its talc-based products caused cancer due to asbestos contamination. The company has been ordered to pay significant damages in US cases and faces a potential £1 billion liability in the UK.
Oct 16, 2025 · 14 articles
Business
Johnson & Johnson: Johnson & Johnson spun off Kenvue two years prior to this acquisition, aiming to make its pharmaceutical and medical device divisions more nimble.
Nov 03, 2025 · 10 articles
Business
Johnson & Johnson: Johnson & Johnson is investing over $1 billion to expand its Vision operations in United States — Jacksonville, Florida, enhancing its manufacturing, packaging, and distribution capabilities for ACUVUE contact lenses. This investment is part of a larger $55 billion commitment to U.S. manufacturing, research, and development, aiming to strengthen its supply chain and meet growing demand.
Jun 15, 2026 · 12 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States and Johnson & Johnson interact across events, view sentiment trends, and discover connected entities.
Open Dashboard